Next Article in Journal
Trioxolone Methyl, a Novel Cyano Enone-Bearing 18βH-Glycyrrhetinic Acid Derivative, Ameliorates Dextran Sulphate Sodium-Induced Colitis in Mice
Previous Article in Journal
Food and Drug Analysis
Previous Article in Special Issue
Protective Effects of Fucoidan Isolated from Celluclast-Assisted Extract of Undaria pinnatifida Sporophylls against AAPH-Induced Oxidative Stress In Vitro and In Vivo Zebrafish Model
Open AccessReview

Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs

1
Shonai Regional Industry Promotion Center, Tsuruoka, Yamagata 997-0052, Japan
2
Tsuruoka Metabolomics Laboratory, National Cancer Center, Mizukami 246-2, Kakuganji, Tsuruoka, Yamagata 975-0052, Japan
3
Division of Translational Research, Exploratory Oncology Research, and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan
*
Author to whom correspondence should be addressed.
Academic Editors: Yasuhito Shimada and Herman P. Spaink
Molecules 2020, 25(10), 2407; https://doi.org/10.3390/molecules25102407
Received: 31 March 2020 / Revised: 18 May 2020 / Accepted: 19 May 2020 / Published: 21 May 2020
(This article belongs to the Special Issue Zebrafish-Based Drug Screening)
Metastasis, a leading contributor to the morbidity of cancer patients, occurs through a multi-step process: invasion, intravasation, extravasation, colonization, and metastatic tumor formation. Each process is not only promoted by cancer cells themselves but is also affected by their microenvironment. Given this complexity, drug discovery for anti-metastatic drugs must consider the interaction between cancer cells and their microenvironments. The zebrafish is a suitable vertebrate animal model for in vivo high-throughput screening studies with physiological relevance to humans. This review covers the zebrafish model used to identify anti-metastatic drugs. View Full-Text
Keywords: zebrafish; metastasis; EMT; angiogenesis; phenotyping screening zebrafish; metastasis; EMT; angiogenesis; phenotyping screening
Show Figures

Figure 1

MDPI and ACS Style

Nakayama, J.; Makinoshima, H. Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs. Molecules 2020, 25, 2407.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop